一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Neuropharmacology >>article
Neuropharmacology

Neuropharmacology

IF: 4.6
Download PDF

Ketamine, benzoate, and sarcosine for treating depression

Published:1 February 2023 DOI: 10.1016/j.neuropharm.2022.109351 PMID: 36423705
Yu-Jung Cheng , Chieh-Hsin Lin , Hsien-Yuan Lane

Abstract

Studies have demonstrated the beneficial therapeutic effects of sarcosine, benzoate, and ketamine (including esketamine and arketamine) on depression. These drugs mainly act by modulating N-methyl-d-aspartate glutamate receptors (NMDARs) and reducing inflammation in the brain. Although ketamine, benzoate, and sarcosine act differently as the antagonists or coagonists of NMDARs, they all have demonstrated efficacy in animal models or human trials. In vitro and in vivo studies have indicated that sarcosine, benzoate, and ketamine exert their anti-inflammatory effects by inhibiting microglial activity. This review summarizes and compares the efficacy of the possible therapeutic mechanisms of sarcosine, benzoate, ketamine, esketamine, and arketamine. These compounds act as both NMDAR modulators and anti-inflammatory drugs and thus can be effective in the treatment of depression.

This article is part of the Special Issue on 'Ketamine and its Metabolites'.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Sarcosine 107-97-1 C3H7NO2 763 suppliers $5.00-$2890.00
Denatonium Benzoate 3734-33-6 C28H34N2O3 589 suppliers $7.00-$1500.00

Similar articles

武陟县| 嘉义县| 迁安市| 南通市| 封丘县| 石林| 浦县| 洪洞县| 华蓥市| 科尔| 来安县| 筠连县| 阿克| 五河县| 玛曲县| 汾阳市| 右玉县| 桦南县| 临海市| 伊金霍洛旗| 淮滨县| 宜君县| 彭山县| 龙里县| 阳春市| 庄河市| 福海县| 西峡县| 普陀区| 根河市| 祁东县| 稷山县| 襄城县| 平凉市| 天长市| 恩平市| 五峰| 青岛市| 永平县| 壶关县| 通河县|